Skip to main content

Table 2 Anti-TB drugs and their dosage used in the trial

From: Efficacy of ultra-short course chemotherapy for new smear positive drug susceptible pulmonary tuberculosis: study protocol of a multicenter randomized controlled clinical trial

Drugs (Abbreviation)

Formulation

Dosage Daily

<50 kg

≥ 50 kg

Isoniazid (H)

100 mg/tablet

300 mg

300 mg

Rifampicin (R)

150 mg/ tablet

450 mg

600 mg

Ethambutol (E)

250 mg/ tablet

750 mg

1000 mg

Pyrazinamid (Z)

250 mg/ tablet

1500 mg

30 mg/kg

Levofloxacin (Lfx)

100 mg/ tablet

600 mg

800 mg